We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
What NPC is going to understand the question sufficiently to answer yes?
2
Conclusions: NPC patients in Cantonese population have obvious family and territorial clustering.
3
After debating the issue, the NPC will vote on it next week.
4
Conclusion: In our institutional study, NPC presents late and in advanced stage.
5
It is an urgent need to uncover novel treatment targets for NPC.
1
Methods and materials: From 1988 to 1998, 68 patients with nasopharynxcancer received conventional external beam therapy followed by a 3D boost.
2
Purpose: To determine whether the use of 3-dimensional (3D) boost for patients with nasopharynxcancer improves local control and reduces the risk of long-term complications.
Usage of nasopharyngeal carcinoma in anglès
1
Conclusion: Cystatin C levels are associated with the prognosis of nasopharyngealcarcinoma patients.
2
Methods: Fourteen patients with nodal metastases from nasopharyngealcarcinoma were studied.
3
After resection of nasopharyngealcarcinoma was performed, the urinary protein level decreased rapidly.
4
Objective: Patients with nasopharyngealcarcinoma experience highly variable outcomes despite receiving similar therapeutic regimens.
5
Conclusion: VEGF plays an important role in the growth and prognosis of nasopharyngealcarcinoma.
6
Conclusion: Simultaneous boost irradiation radiotherapy is feasible in patients with locally advanced nasopharyngealcarcinoma.
7
One patient each with nasopharyngealcarcinoma and fibrous sarcoma were also treated without success.
8
Maxillary osteosarcomas after irradiation for nasopharyngealcarcinoma do not appear to have been described.
9
During this period, the patient was diagnosed with nasopharyngealcarcinoma.
10
These results suggest the EBV association with BC in an endemic area of nasopharyngealcarcinoma.
11
Methods: Quantitative Polymerase Chain Reaction was performed on nasopharyngealcarcinoma and their paired normal tissues.
12
We conducted skin-prick allergen tests on 22 patients with newly diagnosed but not-yet-treated nasopharyngealcarcinoma.
13
We aimed to compare these frameworks in nasopharyngealcarcinoma.
14
We report a very rare case of recurrent nasopharyngealcarcinoma with local involvement of lacrimal sac.
15
Background: Circulating Epstein-Barr virus DNA is a predictor of disease recurrence in patients with nasopharyngealcarcinoma.
16
The primary treatment for nasopharyngealcarcinoma is radiotherapy.